Danaher AI-powered autonomous research lab Ecosystem
Danaher plans AI-guided antibody lab for early 2027
Developing 2 sources
Danaher plans an AI-guided, robot-assisted lab for antibody and reagent research at Abcam, targeting scaled operation in early 2027.
What happened lately
Danaher announced plans for an AI-powered autonomous research lab on October 7. Expected to operate at scale in early 2027, the Abcam-based facility would combine AI design, robotic experiments and feedback from test results to develop antibodies and other affinity reagents. Danaher says the approach could accelerate discovery by up to eight times and eventually increase annual reagent generation by as much as tenfold. These are projections for a future system, not independently verified performance results. Reuters also reported the company’s plan.